Eli Lilly to focus on selling COVID-19 antibody drug combination

FILE PHOTO: A sign is pictured outside an Eli Lilly and Company pharmaceutical manufacturing plant at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. Picture taken March 5, 2021. REUTERS/Mike Segar(Reuters) -Eli Lilly and Co said on Monday it had a revised agreement with the U.S. government for its COVID-19 antibody drug, bamlanivimab,

COVID19's cytokine storm ushers in a local complement storm in the lungs

A new study published in the journal Science Immunology analyzed lung epithelial cells from patients infected with COVID-19 and found the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces the complement system as a dangerous weapon for viral infection. The complement system is an extension of the innate immune system to recognize pathogens and remove

Pro Boxer Ryan Garcia Shared the Diet That Helps Him Stay Lean

Interim lightweight champion Ryan Garcia is consistently ranked among the top lightweight fighters currently active in the boxing world, a fact which can be attributed to his work ethic when it comes to training hard and staying ring-ready. In a new video on his YouTube channel, Garcia and his personal chef Manny Duran break down

Thailand faces growing outbreak ahead of New Year travel

Thai authorities struggled to contain a growing coronavirus outbreak just days before the country’s traditional Songkran New Year’s holiday, when millions of people travel. Health officials reported 559 new infections on Friday, following increases over the previous two days. The government response has so far centered on closures of nightlife venues in 41 provinces for

Parity Whether Anticoagulation Is Halted or Not for Unplanned Cath

Maintaining oral anticoagulation (OAC) throughout an unplanned cardiac catheterization confers no extra risk and might hold some advantages over periprocedural OAC interruption in patients on long-term anticoagulation therapy, suggests a major registry analysis. There was no significant difference in adjusted risk of bleeding or in a primary endpoint that included death and ischemic events whether

Riociguat an Option for Pulmonary Arterial Hypertension When PDE-5 Inhibitors Fail

NEW YORK (Reuters Health) – Patients with pulmonary arterial hypertension (PAH) at intermediate risk of death within a year may be switched from a phosphodiesterase-5 (PDE-5) inhibitor to riociguat to reduce risk, researchers suggest. “Decision making regarding treatment of PAH has become increasingly complex,” Dr. Marius Hoeper of Hanover Medical School in Germany told Reuters

Developing new ways to diagnose preeclampsia

Researchers at Texas A&M University are developing novel tests to diagnose preeclampsia earlier in a pregnancy, even before symptoms occur, allowing hospitals to better treat pregnant patients. Preeclampsia—a pregnancy complication that can lead to organ damage, especially in the liver and kidneys —is one of the leading causes of maternal and baby deaths during pregnancy.

The Pfizer/BioNTech vaccine bet that paid off

With a strategic alliance, 24-hour production and a bit of luck, Pfizer and BioNTech were able to roll out their COVID vaccine at a brisk pace and relatively free of controversy. US pharmaceutical giant Pfizer and BioNTech, a smaller German biotech firm, joined forces on April 9, 2020, as the world reeled from the pandemic,

Sunlight linked with lower COVID-19 deaths, study shows

Sunnier areas are associated with fewer deaths from Covid-19, an observational study suggests. Increased exposure to the sun’s rays—specifically UVA—could act as a simple public health intervention if further research establishes it causes a reduction in mortality rates, experts say. Researchers from the University of Edinburgh compared all recorded deaths from Covid-19 in the continental